ammonium hydroxide has been researched along with Chronic Liver Failure in 16 studies
azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.
Excerpt | Relevance | Reference |
---|---|---|
"Intestinal mannitol is as effective and safe as conventional treatment for reducing hyperammonemia, oxidative stress, and hepatic encephalopathy of CLD patients in the emergency room." | 9.27 | Impact of intestinal mannitol on hyperammonemia, oxidative stress and severity of hepatic encephalopathy in the ED. ( Cruz-Domínguez, MP; Jara, LJ; Montes-Cortés, DH; Novelo-Del Valle, JL; Olivares-Corichi, IM; Rosas-Barrientos, JV, 2018) |
" Low-grade chronic liver failure (CLF) was induced in 3-month old Sprague-Dawley male rats using thioacetamide (TAA, 50 mg·kg-1·day-1) intraperitoneally for 2 weeks." | 7.85 | Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats. ( Ali, SS; Gazzaz, ZJ; Ibraheem, MS; Murad, HA, 2017) |
"Intestinal mannitol is as effective and safe as conventional treatment for reducing hyperammonemia, oxidative stress, and hepatic encephalopathy of CLD patients in the emergency room." | 5.27 | Impact of intestinal mannitol on hyperammonemia, oxidative stress and severity of hepatic encephalopathy in the ED. ( Cruz-Domínguez, MP; Jara, LJ; Montes-Cortés, DH; Novelo-Del Valle, JL; Olivares-Corichi, IM; Rosas-Barrientos, JV, 2018) |
" Low-grade chronic liver failure (CLF) was induced in 3-month old Sprague-Dawley male rats using thioacetamide (TAA, 50 mg·kg-1·day-1) intraperitoneally for 2 weeks." | 3.85 | Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats. ( Ali, SS; Gazzaz, ZJ; Ibraheem, MS; Murad, HA, 2017) |
"Sarcopenia is a common complication of cirrhosis with a negative impact on posttransplant outcome, health-related quality of life (HRQOL), and patient survival." | 2.61 | L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle. ( Butterworth, RF, 2019) |
"Patients with hepatic encephalopathy exhibit sings of energy impairment that may participate in the development of disturbances in neurotransmission." | 2.47 | Acute-on-chronic liver failure: the brain. ( Córdoba, J; García-Martínez, R, 2011) |
"The prevalence of minimal hepatic encephalopathy (MHE), in particular in different subgroups, remains unknown." | 1.91 | Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study. ( Bloom, PP; Danneberg, S; Ehrenbauer, AF; Gabriel, M; Gairing, SJ; Galle, PR; Gioia, S; Labenz, C; Labenz, J; Lauridsen, MM; Lok, AS; Mangini, C; Marquardt, JU; Montagnese, S; Nardelli, S; Nielsen, EJ; Ripoll, C; Sultanik, P; Thabut, D; Weissenborn, K; Zarantonello, L; Zipprich, A, 2023) |
"We included 80 patients with liver cirrhosis (58 men) and 20 healthy controls (11 men)." | 1.40 | Doppler assessment of splanchnic arterial flow in patients with liver cirrhosis: correlation with ammonia plasma levels and MELD score. ( Dimitrijevic, S; Glišić, TM; Jurišić, V; Perišić, MD, 2014) |
"In a rat model of chronic liver failure, hyperammonemia is associated with inadequate compensation by liver and muscle GS activity and increased gut GA activity." | 1.40 | Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats. ( Davies, N; Habtesion, A; Jalan, R; Jover-Cobos, M; Lee, K; Noiret, L; Romero-Gomez, M; Sharma, V, 2014) |
"Dimethyl maleate induced an increase in ROS and MDA in the blood, but not in the brain, of the PCA rats, compared with non-treated PCA rats." | 1.40 | Induction of systemic oxidative stress leads to brain oedema in portacaval shunted rats. ( Bosoi, CR; Rose, CF; Tremblay, M, 2014) |
"The BDL rats developed chronic liver failure and exhibited a decreased discrimination index for short term memory (STM) when compared to the control group." | 1.39 | Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation. ( Escobar, TD; Forgiarini, LF; Hammes, TO; Keiding, S; Leke, R; Meyer, FS; Oliveira, DL; Schousboe, A; Silveira, TR, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 14 (87.50) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Gairing, SJ | 1 |
Mangini, C | 1 |
Zarantonello, L | 1 |
Gioia, S | 1 |
Nielsen, EJ | 1 |
Danneberg, S | 1 |
Gabriel, M | 1 |
Ehrenbauer, AF | 1 |
Bloom, PP | 1 |
Ripoll, C | 1 |
Sultanik, P | 1 |
Galle, PR | 1 |
Labenz, J | 1 |
Thabut, D | 1 |
Zipprich, A | 1 |
Lok, AS | 1 |
Weissenborn, K | 1 |
Marquardt, JU | 1 |
Lauridsen, MM | 1 |
Nardelli, S | 1 |
Montagnese, S | 1 |
Labenz, C | 1 |
Ye, Y | 1 |
Liu, Z | 1 |
Zhao, M | 1 |
Murad, HA | 1 |
Gazzaz, ZJ | 1 |
Ali, SS | 1 |
Ibraheem, MS | 1 |
Montes-Cortés, DH | 1 |
Novelo-Del Valle, JL | 1 |
Olivares-Corichi, IM | 1 |
Rosas-Barrientos, JV | 1 |
Jara, LJ | 1 |
Cruz-Domínguez, MP | 1 |
Xie, G | 1 |
Wang, X | 1 |
Jiang, R | 1 |
Zhao, A | 1 |
Yan, J | 1 |
Zheng, X | 1 |
Huang, F | 1 |
Liu, X | 1 |
Panee, J | 1 |
Rajani, C | 1 |
Yao, C | 1 |
Yu, H | 1 |
Jia, W | 2 |
Sun, B | 1 |
Liu, P | 1 |
Butterworth, RF | 1 |
Pareja, E | 1 |
Gomez-Lechon, MJ | 1 |
Cortes, M | 1 |
Bonora-Centelles, A | 1 |
Castell, JV | 1 |
Mir, J | 1 |
Glišić, TM | 1 |
Perišić, MD | 1 |
Dimitrijevic, S | 1 |
Jurišić, V | 1 |
Jover-Cobos, M | 1 |
Noiret, L | 1 |
Lee, K | 1 |
Sharma, V | 1 |
Habtesion, A | 1 |
Romero-Gomez, M | 1 |
Davies, N | 1 |
Jalan, R | 1 |
Hammad, A | 1 |
Kaido, T | 1 |
Ogawa, K | 1 |
Fujimoto, Y | 1 |
Tomiyama, K | 1 |
Mori, A | 1 |
Uemura, T | 1 |
Uemoto, S | 1 |
Bosoi, CR | 2 |
Tremblay, M | 2 |
Rose, CF | 2 |
Du, WB | 1 |
Pan, XP | 1 |
Yu, XP | 1 |
Yu, CB | 1 |
Lv, GL | 1 |
Chen, Y | 1 |
Li, LJ | 1 |
García-Martínez, R | 1 |
Córdoba, J | 1 |
Yang, X | 1 |
Huynh, J | 1 |
Parent-Robitaille, C | 1 |
Jiang, W | 1 |
Fehérvári, I | 1 |
Nemes, B | 1 |
Görög, D | 1 |
Gerlei, Z | 1 |
Kóbori, L | 1 |
Leke, R | 1 |
Oliveira, DL | 1 |
Forgiarini, LF | 1 |
Escobar, TD | 1 |
Hammes, TO | 1 |
Meyer, FS | 1 |
Keiding, S | 1 |
Silveira, TR | 1 |
Schousboe, A | 1 |
3 reviews available for ammonium hydroxide and Chronic Liver Failure
Article | Year |
---|---|
L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle.
Topics: Ammonia; Dipeptides; End Stage Liver Disease; Humans; Hyperammonemia; Liver; Sarcopenia; Treatment O | 2019 |
Acute-on-chronic liver failure: the brain.
Topics: Ammonia; Brain; End Stage Liver Disease; Hepatic Encephalopathy; Humans; Liver Failure, Acute | 2011 |
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence- | 2012 |
1 trial available for ammonium hydroxide and Chronic Liver Failure
Article | Year |
---|---|
Impact of intestinal mannitol on hyperammonemia, oxidative stress and severity of hepatic encephalopathy in the ED.
Topics: Adult; Ammonia; Biomarkers; Diuretics, Osmotic; Drug Administration Routes; End Stage Liver Disease; | 2018 |
12 other studies available for ammonium hydroxide and Chronic Liver Failure
Article | Year |
---|---|
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study.
Topics: Ammonia; End Stage Liver Disease; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Prevalence; Psych | 2023 |
CLIF-OF >9 predicts poor outcome in patients with Amanita phalloides poisoning.
Topics: Amanita; Ammonia; Area Under Curve; China; End Stage Liver Disease; Female; Humans; Logistic Models; | 2021 |
Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
Topics: Alanine Transaminase; Ammonia; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Bip | 2017 |
Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure.
Topics: Ammonia; Animals; Bile Acids and Salts; Cell Line; Disease Models, Animal; End Stage Liver Disease; | 2018 |
Human hepatocyte transplantation in patients with hepatic failure awaiting a graft.
Topics: Adult; Ammonia; End Stage Liver Disease; Hepatitis C, Chronic; Hepatocytes; Humans; Liver Function T | 2013 |
Doppler assessment of splanchnic arterial flow in patients with liver cirrhosis: correlation with ammonia plasma levels and MELD score.
Topics: Adult; Aged; Ammonia; Blood Flow Velocity; End Stage Liver Disease; Female; Hepatic Artery; Humans; | 2014 |
Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
Topics: Ammonia; Animals; Bile Ducts; Disease Models, Animal; End Stage Liver Disease; Glutamate-Ammonia Lig | 2014 |
Perioperative changes in nutritional parameters and impact of graft size in patients undergoing adult living donor liver transplantation.
Topics: ABO Blood-Group System; Adolescent; Adult; Aged; Amino Acids, Branched-Chain; Ammonia; Blood Group I | 2014 |
Induction of systemic oxidative stress leads to brain oedema in portacaval shunted rats.
Topics: Ammonia; Analysis of Variance; Animals; Biomarkers; Brain Edema; End Stage Liver Disease; Glutathion | 2014 |
Effects of plasma from patients with acute on chronic liver failure on function of cytochrome P450 in immortalized human hepatocytes.
Topics: Ammonia; Anesthetics, Local; Blood Proteins; Cell Line, Transformed; Cytochrome P-450 Enzyme System; | 2010 |
Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure.
Topics: Ammonia; Animals; Blood-Brain Barrier; Brain Edema; Disease Models, Animal; End Stage Liver Disease; | 2012 |
Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation.
Topics: Ammonia; Animals; Bile Ducts; End Stage Liver Disease; Hepatic Encephalopathy; Hyperammonemia; Ligat | 2013 |